Home > Boards > US Listed > Cannabis >

Zynerba Pharmaceuticals (ZYNE)

ZYNE RSS Feed
Add ZYNE Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 5/18/2019 9:46:47 PM - Followers: 99 - Board type: Free - Posts Today: 0


Zynerba Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing and commercializing synthetic cannabinoid therapeutics formulated for transdermal delivery. The Company is evaluating approximately two product candidates, ZYN002 and ZYN001, in over five indications. The Company intends to study ZYN002 in patients with refractory epilepsy, osteoarthritis and Fragile X syndrome. The Company's ZYN002 is synthetic cannabidiol (CBD) formulated as a permeation-enhanced gel for transdermal delivery. ZYN002 is being developed as a clear that is designed to provide controlled drug delivery with once- or twice-daily dosing. ZYN001 is a pro-drug of tetrahydrocannabinol (THC) that enables transdermal delivery through a patch. The Company intends to test the ZYN001 patch for application to the arm, back and thigh. The Company intends to study ZYN001 in patients with fibromyalgia and peripheral neuropathic pain.

Investor Relations

Corporate Profile

Zynerba (NASDAQ: ZYNE) is pioneering the development of patent-protected, next-generation synthetic cannabinoid therapeutics formulated for transdermal delivery. Its two lead product candidates in development include ZYN002 and ZYN001, which are being evaluated in five indications. ZYN002 is the first and only synthetic cannabidiol (CBD) formulated as a permeation-enhanced gel for transdermal delivery. In June 2016, the company initiated the STAR 1 Phase 2 clinical trial in refractory epilepsy patients and in August 2016, initiated the STOP Phase 2 clinical trial in patients with osteoarthritis of the knee. A Phase 2 clinical trial in patients with Fragile X syndrome will be initiated in the second half of 2016. 

ZYN001, a prodrug of THC that enables transdermal delivery through the skin and circulatory system via a patch, is in preclinical development. A Phase 1 clinical trial is planned in the first half of 2017.

In August 2015, Zynerba completed an initial public offering, raising net proceeds of $42.1 million. As of June 30, 2016, cash and cash equivalents totaled $32.1 million, which is projected to fund five Phase 2 clinical trials through 2017.





Zynerba Pharmaceuticals, Inc., (Nasdaq: ZYNE) announced today the pricing of its initial public offering of 3 million shares of common stock at a public offering price of $14.00 per share, before underwriting discounts. All of the shares in the offering are being sold by Zynerba. In addition, Zynerba has granted the underwriters an option to purchase up to 450,000 additional shares of common stock at the public offering price, less the underwriting discount. Zynerba's common stock has been approved for listing on the NASDAQ Global Market and is expected to begin trading under the symbol "ZYNE" on August 5, 2015.

Jefferies LLC and Piper Jaffray & Co. are acting as joint book-running managers for the offering, and Canaccord Genuity Inc. and Oppenheimer & Co. Inc. are acting as co-managers for the offering. This offering is being made only by means of a prospectus.



Extremely low float:

Fundamentals

A table providing the fundamentals of the stock
EPS (TTM) 9/30/2016 | -2.47
P/E Ratio 9/30/2016 | --
Market Cap Micro Cap | 146M
Shares Outstanding 9.95M
Float 7.2M

 

ZYNE
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ZYNE News: Quarterly Report (10-q) 05/08/2019 09:02:37 AM
ZYNE News: Current Report Filing (8-k) 05/08/2019 07:31:32 AM
ZYNE News: Additional Proxy Soliciting Materials (definitive) (defa14a) 05/06/2019 04:36:23 PM
ZYNE News: Current Report Filing (8-k) 05/06/2019 04:33:25 PM
ZYNE News: Current Report Filing (8-k) 05/06/2019 07:32:37 AM
PostSubject
#1455   :) Fress 05/18/19 09:46:47 PM
#1454   How sweet it is. See you back in dhbuzz 05/18/19 09:21:17 PM
#1453   1. Rule number 1. Let your runners run. Fress 05/18/19 06:40:14 PM
#1452   Why ZYNE going way higher. FRAGILE X CBD Fress 05/18/19 04:37:56 PM
#1451   Here is who we are going to soon dhbuzz 05/18/19 10:16:47 AM
#1450   IS ZYNERBA PHARMACEUTICALS, INC. (ZYNE) A KEEPER? dhbuzz 05/18/19 09:49:26 AM
#1449   On May 6 of 2019 Zygel was "FAST TRACKED" dhbuzz 05/18/19 09:24:21 AM
#1448   ZYNE will be getting fast tracked for multiple Fress 05/18/19 08:38:34 AM
#1447   ZYNE is also working on a biosynthetic THC Fress 05/17/19 07:34:08 PM
#1446   Bring it down to Me please KingTigerII 05/17/19 02:31:18 PM
#1445   Load some 14’s end of day KingTigerII 05/17/19 02:31:02 PM
#1444   I'm not short but I think we have dbmich 05/17/19 11:42:31 AM
#1443   LOL! I'll try that next time I need a Glider549 05/17/19 11:01:36 AM
#1442   17.00+ close by end of the day. Fress 05/17/19 10:19:57 AM
#1441   https://www.bing.com/videos/search?q=GOMER+PYLE+SHAZAM+U+TUBE&&view=detail&mid=0 dhbuzz 05/17/19 10:01:15 AM
#1440   You would think his sheep would catch on Glider549 05/17/19 09:52:09 AM
#1439   Here comes Clay and his followers put your Fress 05/17/19 09:44:56 AM
#1438   I'll up your SHAZAM with a BOOM!!! This stock Glider549 05/17/19 09:44:42 AM
#1437   SHAZAM ! dhbuzz 05/16/19 11:58:36 PM
#1436   Beast greenwillow 05/16/19 06:36:25 PM
#1435   True, but it hasnt even cleared the roof Glider549 05/16/19 05:04:33 PM
#1434   I do not think that trees grow to Leonard McKinley 05/16/19 04:42:26 PM
#1433   * * $ZYNE Video Chart 05-16-2019 * * ClayTrader 05/16/19 04:40:13 PM
#1432   I’m loading up if it does jhainline 05/16/19 03:58:13 PM
#1431   Might be turn down tomorrow when shorts come Fress 05/16/19 03:28:08 PM
#1430   20.00+ plus end of the Q2 Fress 05/16/19 02:45:22 PM
#1429   ZYNE already has its main drug fast tracked. Glider549 05/16/19 02:42:58 PM
#1428   Certainly something to keep in mind, if the morokoy 05/16/19 01:09:11 PM
#1427   Is the price of synthetic CBD going to Leonard McKinley 05/16/19 12:36:45 PM
#1426   Three months ago I owed eight stocks. Now I Glider549 05/16/19 12:03:12 PM
#1425   This company rocks! I just matched my yearly average Glider549 05/16/19 12:00:15 PM
#1424   36.50 Break is coming sooner than later. Fress 05/16/19 11:25:20 AM
#1423   Buy ZYNE now or cry later! This could PatLA818 05/16/19 10:52:39 AM
#1422   Come on guys can’t we all just get KingTigerII 05/16/19 09:11:51 AM
#1421   clay I think ya made Fress mad. dhbuzz 05/15/19 11:30:43 PM
#1420   lol.... well played... ClayTrader 05/15/19 12:05:10 PM
#1419   Are you the one running this right now ? KingTigerII 05/15/19 10:24:34 AM
#1418   Are you a whale dude! KingTigerII 05/15/19 10:23:49 AM
#1417   I love dropping that hammer on Clay and Fress 05/15/19 10:23:19 AM
#1416   Would love to see 14+ today. KingTigerII 05/15/19 09:54:23 AM
#1415   News & hammers dropping multiple catalysts in Q2 Fress 05/15/19 09:21:31 AM
#1414   Why ZYNE going way higher. FRAGILE X CBD Fress 05/15/19 07:57:37 AM
#1413   Our Time is coming. Fress 05/14/19 10:46:55 PM
#1412   HAMMER TIME !!!! dhbuzz 05/14/19 10:42:46 PM
#1411   Load up sit back and watch your investment Fress 05/14/19 07:54:38 PM
#1410   this has good data, its a 700M dollar Fress 05/14/19 05:22:01 PM
#1409   With so many up coming catalysts, the current Glider549 05/14/19 04:34:02 PM
#1408   ZYNE is about to drop another hammer so Fress 05/14/19 03:52:07 PM
#1407   1.The deal here is simple. . Know what Fress 05/14/19 03:23:09 PM
#1406   Break 14 today maybe? KingTigerII 05/14/19 10:28:44 AM
PostSubject